Ron Hunt

Ron is a Managing Director at New Leaf Venture Partners, where he focuses on early- to late-stage investments in biopharmaceuticals. He was one of the founders of New Leaf in 2005, and today has over two decades of experience investing in and building companies focused on developing novel medicines that address important unmet medical needs. Prior to New Leaf, Ron was a partner at the Sprout Group, a venture capital firm, and was a consultant with Coopers & Lybrand Consulting and The Health Care Group, Inc. He previously held various sales and marketing positions at Johnson & Johnson and SmithKline Beecham Pharmaceuticals PLC. Ron currently serves as a board member and is chairman of the board of Harpoon Therapeutics, Inc. and is a board member at Iterum Therapeutics, Ltd., a clinical-stage therapeutics company. Ron is also on the boards of a number of private pharmaceutical companies. He previously served on the board of directors of Neuronetics, Inc., a medical device company.

Ron earned a B.S. from Cornell University and an MBA from the Wharton School of the University of Pennsylvania.